Minerva Neurosciences Inc
Statements
Cash Flow
Minerva Neurosciences Inc (NERV) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -13,345 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.7 | -8.9 | -6.0 | -6.8 | 25 | -8.9 | -11 | -11 | -10.0 | -9.8 | -9.6 | -10 | -9.5 | -14 | -9.2 | -7.6 | -9.9 | -7.2 | -5.2 | -5.9 | -8.6 | -4.8 | -5.8 | -5.2 | -9.5 | -4.1 | -0.1 | -3.9 | -4.8 | -6.0 | -6.1 | -3.9 | -4.4 | -5.2 | -5.2 | -2.0 | -2.9 | -4.5 | -5,427 | -13,345 | -18,779 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 102 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 0.9 | 1.0 | 1.3 | 1.2 | 1.2 | 1.3 | 2.1 | 1.9 | 2.3 | 1.9 | 2.5 | 2.3 | 2.2 | 2.2 | 2.2 | 3.5 | 2.1 | 2.0 | 1.5 | 1.4 | 1.1 | 1.2 | 1.1 | 1.1 | 1.0 | 0.9 | 0.4 | 0.6 | 0.4 | 0.6 | 0.4 | 0.3 | 0.3 | 0.2 | 0.2 | 0.3 | 0.3 | 0.5 | 8,710 | 2,273 | 10,984 | |
| 0.9 | 1.0 | 1.3 | 1.2 | 1.2 | -8.1 | 2.1 | 1.9 | 2.3 | 1.9 | 2.5 | 2.3 | 2.2 | 19 | 2.2 | 3.5 | 2.1 | 2.0 | 1.5 | 3.0 | 2.8 | 16 | 2.8 | 2.9 | -0.2 | 2.9 | 3.5 | 0.6 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 2.7 | -0.6 | 3.2 | 1.7 | 35 | -0.9 | -0.6 | -0.6 | -0.2 | 1.5 | 4.0 | 0.2 | 2.3 | -3.1 | 0.8 | -41 | -3.9 | -1.8 | 0.7 | 1.6 | -2.2 | 0.1 | 1.1 | 0.6 | -5.5 | -0.3 | 4.5 | -0.3 | 0.5 | 0.2 | -0.2 | 1.6 | -0.6 | -1.1 | -1.1 | 0.9 | -0.4 | -0.5 | 2.0 | -5.1 | -4.0 | |
| 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 8.4 | 17,800 | -16 | -11 | -80 | 0.0 | 31 | 36 | 30 | -27 | -11 | 7.4 | 20 | -2.3 | 17 | 4.5 | 3.0 | 24,504 | – | – | – | – | – | – | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | – | – | – | -45,294 | -4,833 | – | |
| 0.0 | 57,442 | 0.0 | 0.0 | 0.5 | 47,122 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -0.2 | 0.2 | 9.6 | 0.3 | 0.0 | -0.4 | 0.0 | 0.0 | 0.5 | 0.2 | 0.5 | 0.5 | 0.5 | 0.0 | 0.8 | 5.3 | 7.1 | – | – | – | – | – | – | – | – | – | – | 20 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -0.4 | -1.2 | -1.2 | -1.2 | -1.2 | -1.3 | -1.3 | -1.3 | -1.4 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -0.5 | 0.1 | 8.4 | -1.0 | 41 | -1.3 | -1.3 | -1.3 | -0.9 | 0.2 | 0.5 | 0.0 | 0.0 | 0.0 | 0.8 | 5.3 | 7.1 | 13,225 | 60 | 60 | 60 | 59,940 | 0.0 | 0.0 | 0.0 | 0.0 | 20 | 20 | -0.1 | 19,584 | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 74 | 1,079 | 10,170 | 11,324 | |
| 3.2 | -8.9 | -14 | -19 | -14 | -10 | 19 | 24 | 19 | -37 | -20 | -2.8 | 10 | -16 | 8.6 | 2.2 | 0.3 | -7.2 | 55 | -5.9 | -8.6 | -4.8 | -5.8 | -5.2 | -9.5 | -4.1 | -0.1 | 16 | -4.9 | -6.0 | -6.1 | -3.9 | -4.4 | -5.2 | -5.2 | -2.0 | -3.0 | 70 | -49,642 | -8,008 | -57,583 | |
| -4.7 | -8.9 | -6.0 | -6.8 | 25 | -8.9 | -11 | -11 | -10.0 | -9.8 | -9.6 | -10 | -9.5 | -14 | -9.2 | -7.6 | -9.9 | -7.2 | -5.2 | -5.9 | -8.6 | -4.8 | -5.8 | -5.2 | -9.5 | -4.1 | -0.1 | -3.9 | -4.8 | -6.0 | -6.1 | -3.9 | -4.4 | -5.2 | -5.2 | -2.0 | -2.9 | -4.5 | -5,427 | -13,345 | -18,779 |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.